Charles River Labs to Open Preclinical Facility in Shanghai

Wednesday, October 15, 2008 12:41 PM

Preclinical research powerhouse Charles River Laboratories is expanding its global reach with a new 60,000-square-foot facility in Shanghai, China.

Slated to open in early 2009, the new facility will support a growing demand from multinational pharmaceutical clients for outsourced drug development services, according to a Charles River release.

“As our clients make their initial forays into China, we are creating a center of excellence that embodies global best practices alongside them,” said James Foster, president, chairman and CEO of Charles River. “Our clients have come to appreciate and rely on the expertise Charles River brings to their drug development efforts, and the convenience of our facilities in close proximity. The same high standards of research, safety, humane care and good laboratory practices that globally distinguish Charles River are replicated in our Shanghai facility. Expanding into this arena is a marathon—not a sprint—and this facility marks the first step in our journey.”

In March 2007, Charles River announced a joint venture with Shanghai BioExplorer, a Shanghai-based provider of preclinical services, to form Charles River Preclinical Services Greater China.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs